Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy

Research output: Contribution to journal › Review › Research › peer-review

Standard

Bacteriophage Interactions with Marine Pathogenic Vibrios : Implications for Phage Therapy. / Kalatzis, Panagiotis; Castillo Bermúdez, Daniel Elías; Katharios, Pantelis; Middelboe, Mathias.

In: Antibiotics, Vol. 7, No. 1, 15, 2018.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Kalatzis, P, Castillo Bermúdez, DE, Katharios, P & Middelboe, M 2018, 'Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy', Antibiotics, vol. 7, no. 1, 15. https://doi.org/10.3390/antibiotics7010015

APA

Kalatzis, P., Castillo Bermúdez, D. E., Katharios, P., & Middelboe, M. (2018). Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy. Antibiotics, 7(1), [15]. https://doi.org/10.3390/antibiotics7010015

Vancouver

Kalatzis P, Castillo Bermúdez DE, Katharios P, Middelboe M. Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy. Antibiotics. 2018;7(1). 15. https://doi.org/10.3390/antibiotics7010015

Author

Kalatzis, Panagiotis ; Castillo Bermúdez, Daniel Elías ; Katharios, Pantelis ; Middelboe, Mathias. / Bacteriophage Interactions with Marine Pathogenic Vibrios : Implications for Phage Therapy. In: Antibiotics. 2018 ; Vol. 7, No. 1.

Bibtex

@article{686eeaa551114aaa99a7a857ee347f6d,
title = "Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy",
abstract = "A global distribution in marine, brackish, and freshwater ecosystems, in combinationwith high abundances and biomass, make vibrios key players in aquatic environments, as wellas important pathogens for humans and marine animals. Incidents of Vibrio-associated diseases(vibriosis) in marine aquaculture are being increasingly reported on a global scale, due to the fastgrowth of the industry over the past few decades years. The administration of antibiotics has beenthe most commonly applied therapy used to control vibriosis outbreaks, giving rise to concerns aboutdevelopment and spreading of antibiotic-resistant bacteria in the environment. Hence, the idea ofusing lytic bacteriophages as therapeutic agents against bacterial diseases has been revived duringthe last years. Bacteriophage therapy constitutes a promising alternative not only for treatment,but also for prevention of vibriosis in aquaculture. However, several scientific and technologicalchallenges still need further investigation before reliable, reproducible treatments with commercialpotential are available for the aquaculture industry. The potential and the challenges of phage-basedalternatives to antibiotic treatment of vibriosis are addressed in this review.",
author = "Panagiotis Kalatzis and {Castillo Berm{\'u}dez}, {Daniel El{\'i}as} and Pantelis Katharios and Mathias Middelboe",
year = "2018",
doi = "10.3390/antibiotics7010015",
language = "English",
volume = "7",
journal = "Antibiotics",
issn = "2079-6382",
publisher = "M D P I AG",
number = "1",

}

RIS

TY - JOUR

T1 - Bacteriophage Interactions with Marine Pathogenic Vibrios

T2 - Implications for Phage Therapy

AU - Kalatzis, Panagiotis

AU - Castillo Bermúdez, Daniel Elías

AU - Katharios, Pantelis

AU - Middelboe, Mathias

PY - 2018

Y1 - 2018

N2 - A global distribution in marine, brackish, and freshwater ecosystems, in combinationwith high abundances and biomass, make vibrios key players in aquatic environments, as wellas important pathogens for humans and marine animals. Incidents of Vibrio-associated diseases(vibriosis) in marine aquaculture are being increasingly reported on a global scale, due to the fastgrowth of the industry over the past few decades years. The administration of antibiotics has beenthe most commonly applied therapy used to control vibriosis outbreaks, giving rise to concerns aboutdevelopment and spreading of antibiotic-resistant bacteria in the environment. Hence, the idea ofusing lytic bacteriophages as therapeutic agents against bacterial diseases has been revived duringthe last years. Bacteriophage therapy constitutes a promising alternative not only for treatment,but also for prevention of vibriosis in aquaculture. However, several scientific and technologicalchallenges still need further investigation before reliable, reproducible treatments with commercialpotential are available for the aquaculture industry. The potential and the challenges of phage-basedalternatives to antibiotic treatment of vibriosis are addressed in this review.

AB - A global distribution in marine, brackish, and freshwater ecosystems, in combinationwith high abundances and biomass, make vibrios key players in aquatic environments, as wellas important pathogens for humans and marine animals. Incidents of Vibrio-associated diseases(vibriosis) in marine aquaculture are being increasingly reported on a global scale, due to the fastgrowth of the industry over the past few decades years. The administration of antibiotics has beenthe most commonly applied therapy used to control vibriosis outbreaks, giving rise to concerns aboutdevelopment and spreading of antibiotic-resistant bacteria in the environment. Hence, the idea ofusing lytic bacteriophages as therapeutic agents against bacterial diseases has been revived duringthe last years. Bacteriophage therapy constitutes a promising alternative not only for treatment,but also for prevention of vibriosis in aquaculture. However, several scientific and technologicalchallenges still need further investigation before reliable, reproducible treatments with commercialpotential are available for the aquaculture industry. The potential and the challenges of phage-basedalternatives to antibiotic treatment of vibriosis are addressed in this review.

U2 - 10.3390/antibiotics7010015

DO - 10.3390/antibiotics7010015

M3 - Review

C2 - 29495270

VL - 7

JO - Antibiotics

JF - Antibiotics

SN - 2079-6382

IS - 1

M1 - 15

ER -

ID: 198415596